Canadian firm Relevium Technologies says it will file its belated financial statements by the end of January 2022, which would lift a ban placed by regulators on sales of stock by the company’s management.
The cash injection will enable Verdify to roll-out global expansion plans and enhance data collection protocols, brand endorsements and digital link ups with major retailers.
Mérieux NutriSciences has announced the acquisition of Utah firm Dyad Labs as the company bolsters its footprint in the dietary supplements industry in North America.
Network marketing company LifeVantage is planning to refocus on a foundational product as part of a personalization strategy in an attempt to arrest a soft spot in revenues.
The US Securities and Exchange Commission has indicted CanaFarma hemp and its two cofounders with fraudulently raising about $15 million from investors, and misappropriating approximately $4 million of that for personal and nonbusiness purposes.
A recent report on sales of botanical supplements was mostly very good news for the industry. But one prominent ingredient — turmeric — saw sales flatten or even decline.
Cyanotech, a legacy firm producing spirulina and astaxanthin supplements, reported a return to strong growth after a year of flat financial results in 2020.
Natural Grocers reported a decrease in sales momentum in the third quarter of its fiscal 2021 when compared to last year’s pandemic-fueled buying spree. But the company’s private label supplements sales buoyed results.
In concord with a trend affecting most of the multi level marketing companies selling dietary supplements, Nature’s Sunshine has posted another quarter of record results, buoyed by surging sales in Asia, South America and Poland.
Usana Health Sciences has reached another earnings milestone as the company topped $330 million in revenue for its most recent financial reporting period.
A new $15 million investment will help prebiotic manufacturer Prenexus Health finally hit commercial scale production for its unique prebiotic xylooligosaccharide ingredient.
In an industry populated with many privately held firms, two dietary supplement manufacturers — Thorne and Nutraceutical International — have filed for IPOs, each set at $100 million as the initial target size of the deals.
Nutrachampion Loren Israelsen said he’s grateful that the award signifies that decades later his peers think he’s still contributing in a meaningful way to the industry that he helped create.
